Chronic wounds arise from interruption of normal healing due to many potential pathophysiological factors. Monitoring these multivariate factors can provide personalized diagnostic information for wound management, but current sensing technologies use complex laboratory tests or track a limited number of wound parameters. We report a flexible biosensing platform for multiplexed profiling of the wound microenvironment, inflammation, and infection state at the point of care. This platform integrates a sensor array for measuring inflammatory mediators [tumor necrosis factor–α, interleukin-6 (IL-6), IL-8, and transforming growth factor–β1], microbial burden (Staphylococcus aureus), and physicochemical parameters (temperature and pH) with a microfluidic wound exudate collector and flexible electronics for wireless, smartphone-based data readout. We demonstrate in situ multiplexed monitoring in a mouse wound model and also profile wound exudates from patients with venous leg ulcers. This technology may facilitate more timely and personalized wound management to improve chronic wound healing outcomes.
Multiscale biohybrid systems integrating living materials with minimally invasive in vivo fabrication offer new opportunities for precise diagnosis, physiological monitoring, and tissue regeneration. This review provides a unified perspective on their design and therapeutic integration, organizing recent advances across multiscale material design, minimally invasive fabrication, spatiotemporal co‐engineering, and functional applications. Three emerging principles are identified: multiscale coupling bridges material architectures with cellular and tissue responses; spatiotemporal coordination integrates precise in vivo construction with dynamic material and biological evolution; and sensing–regeneration feedback extends biohybrid systems from passive repair toward responsive therapeutic regulation. Building on these principles, we highlight machine learning–assisted material discovery, multi‐site fabrication, and intelligent feedback control as key directions for developing adaptive, closed‐loop therapeutic systems. Together, these insights provide design guidance for translating minimally invasive multiscale biohybrid systems toward next‐generation patient‐centered healthcare.